Latest / Breastcancer.org Podcast

Metabolite Markers -- Heard in the Halls: Voices From the 2019 American Society of Clinical Oncology Annual Meeting
Dr. Liz O'Day talks about a test her company is developing that uses metabolites in blood to assess whether a person with metastatic breast cancer will respond to CDK4/6 inhibitors.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.